We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-6.5%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$239M
AUM Growth
-$14.3M
Cap. Flow
+$18M
Cap. Flow %
7.56%
Top 10 Hldgs %
75.03%
Holding
66
New
2
Increased
22
Reduced
19
Closed
3

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$15.5M
2
GSLC icon
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
+$2.43M
3
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$1.67M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$714K
5
AMLP icon
Alerian MLP ETF
AMLP
+$650K

Top Sells

Rank Stock Value
1
BMR
BIOMED REALTY TRUST INC
BMR
+$1.53M
2
VV icon
Vanguard Morningstar Large-Cap ETF
VV
+$944K
3
VGK icon
Vanguard FTSE Europe ETF
VGK
+$450K
4
VDE icon
Vanguard Energy ETF
VDE
+$377K
5
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$365K

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.84%
2 Healthcare 15.89%
3 Real Estate 0.44%
4 Financials 0.27%
5 Materials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$32.3B
$1.09M 0.46%
4,196
– –
ARE icon
27
Alexandria Real Estate Equities
ARE
$8.87B
$1.05M 0.44%
11,529
– –
SPY icon
28
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$1.02M 0.43%
4,941
-19
-0.4% -$3.71K
AMLP icon
29
Alerian MLP ETF
AMLP
$13.4B
$926K 0.39%
16,957
+12,787
+307% +$650K
NBIX icon
30
Neurocrine Biosciences
NBIX
$15.7B
$870K 0.36%
22,000
+7,000
+47% +$278K
EWJ icon
31
iShares MSCI Japan ETF
EWJ
$22.7B
$675K 0.28%
14,788
-3,146
-18% -$142K
VDE icon
32
Vanguard Energy ETF
VDE
$10.7B
$642K 0.27%
7,478
-4,710
-39% -$377K
SCHE icon
33
Schwab Emerging Markets Equity ETF
SCHE
$13B
$628K 0.26%
30,242
+3,014
+11% +$56.7K
MON
34
DELISTED
Monsanto Co
MON
$535K 0.22%
6,098
– –
MBFI
35
DELISTED
MB Financial Corp
MBFI
$510K 0.21%
15,705
– –
AAXJ icon
36
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
$488K 0.2%
8,930
– –
DSI icon
37
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
$481K 0.2%
12,558
-580
-4% -$21K
RLY icon
38
State Street Multi-Asset Real Return ETF
RLY
$1.35B
$467K 0.2%
20,130
-296
-1% -$6.49K
DXJ icon
39
WisdomTree Japan Hedged Equity Fund
DXJ
$7.34B
$462K 0.19%
10,581
-989
-9% -$43.6K
ZVO
40
DELISTED
Zovio Inc. Common Stock
ZVO
$444K 0.19%
44,061
– –
CMBS icon
41
iShares CMBS ETF
CMBS
$472M
$411K 0.17%
7,910
– –
VWO icon
42
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$411K 0.17%
11,897
-93
-0.8% -$2.92K
KND
43
DELISTED
Kindred Healthcare
KND
$409K 0.17%
33,078
– –
MLPX icon
44
Global X MLP & Energy Infrastructure ETF
MLPX
$3.63B
$373K 0.16%
10,834
– –
EBND icon
45
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$364K 0.15%
13,503
– –
TSLA icon
46
Tesla
TSLA
$1.38T
$358K 0.15%
23,400
+3,150
+16% +$41.4K
CELG
47
DELISTED
Celgene Corp
CELG
$310K 0.13%
3,100
+1,000
+48% +$103K
AGIO icon
48
Agios Pharmaceuticals
AGIO
$1.99B
$284K 0.12%
+7,000
New +$299K
EWC icon
49
iShares MSCI Canada ETF
EWC
$6.85B
$280K 0.12%
11,800
-1,092
-8% -$23.4K
DBEF icon
50
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.38B
$279K 0.12%
10,918
+2,127
+24% +$53.7K
1
2
3

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Callan Capital held 66 positions worth $239M, down 5.6% from $253M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Callan Capital deployed $18M of net new capital in Q1 2016, opening 2 new positions and adding to 22 existing holdings. Its largest new stake was Agios Pharmaceuticals: 7,000 shares worth $284K.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 70% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $450K trimmed.

  • Callan Capital's largest Q1 2016 buy was Agios Pharmaceuticals: 7,000 shares worth $284K.
  • Callan Capital added most to Vanguard FTSE All-World ex-US ETF in Q1 2016, an estimated $15.5M increase.
  • Callan Capital's biggest Q1 2016 reduction was Vanguard FTSE Europe ETF, cutting an estimated $450K.
  • Callan Capital fully exited BIOMED REALTY TRUST INC in Q1 2016, selling an estimated $1.53M.
  • Callan Capital's ten largest holdings make up 75% of its $239M portfolio in Q1 2016.
  • Callan Capital opened 2 new positions and closed 3 in Q1 2016.
  • Callan Capital's portfolio value fell 5.6% quarter-over-quarter to $239M.

Based on Callan Capital's 13F filing for Q1 2016, filed 11 May 2016.